Young adults carrying a C9orf72 repeat expansion had smaller thalamic volumes than their variant-negative relatives by their mid twenties, and those volumes stayed largely flat between ages 18 and 30, according to a longitudinal cohort study posted as a preprint on medRxiv on 10 June 2026 and not yet peer reviewed. The study, drawn from the FTD Prevention Initiative across sites in Europe, Canada and the United States, compared 147 carriers of C9orf72, MAPT or GRN variants with 113 familial non-carriers, all aged 18 to 30, with an average of 2.1 study visits each. At the reference age of 26, the modelled thalamic difference in C9orf72 carriers was about 983 cubic millimetres (standard error 317.0, p=0.0046).

The pattern was not uniform across the three genes. Trajectories of rostral anterior cingulate volume also diverged in C9orf72 carriers, who stayed relatively stable while non-carriers showed the age-appropriate decline expected in the twenties, though that effect was small (p=0.035). For MAPT and GRN carriers, the authors report little to no difference from non-carriers in total brain, cortical or subcortical volumes, either at a given age or over time. No differences were found between carriers and non-carriers in executive function, or in plasma neurofilament light or glial fibrillary acidic protein, in any genetic group.

The question behind the work is whether variants that cause frontotemporal dementia in mid or later life also shape the brain as it develops. An earlier cross-sectional analysis of young adults in the Genetic FTD Initiative, published in Brain in December 2022, found smaller volumes in C9orf72 carriers at a mean age of 26 and larger total intracranial volumes in GRN and MAPT carriers. The new analysis, following the same age band over repeated visits rather than at a single point, reads its stable trajectories as support for a neurodevelopmental contribution in C9orf72, with, in the authors' words, "minimal early neurodegeneration" in young adulthood.

The counterpoint is in the study's own framing. The preprint has not been through peer review; the cingulate finding is a small effect at a conventional significance threshold; participants averaged only two visits, so individual trajectories rest on few data points; and the authors describe the evidence for an absence of difference in biomarkers and cognition as modest rather than conclusive. A flat trajectory across a twelve-year window in early adulthood is also not the same as a flat trajectory later, when atrophy in genetic FTD is well documented to begin.